Fibrin and fibrinolysis in infection and host defense, J Thromb Haemost, vol.5, issue.1, pp.24-31, 2007. ,
Membrane-anchored serine proteases in vertebrate cell and developmental biology, Annu Rev Cell Dev Biol, vol.27, pp.213-235, 2011. ,
Complement and its role in innate and adaptive immune responses, Cell Res, vol.20, issue.1, pp.34-50, 2010. ,
Multiple roles of the coagulation protease cascade during virus infection, Blood, vol.123, issue.17, pp.2605-2613, 2014. ,
Mechanisms of thrombus formation, N Engl J Med, vol.359, issue.9, pp.938-949, 2008. ,
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis, Arterioscler Thromb Vasc Biol, vol.27, issue.8, pp.1687-1693, 2007. ,
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis, Am J Pathol, vol.134, issue.5, pp.1087-1097, 1989. ,
The molecular basis of blood coagulation, Cell, vol.53, issue.4, pp.505-518, 1988. ,
Serine proteases of the complement system, Biochem Soc Trans, vol.28, issue.5, pp.545-550, 2000. ,
Zymogen activation, inhibition, and ectodomain shedding of matriptase, Front Biosci, vol.13, pp.621-635, 2008. ,
Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor, Eur J Biochem, vol.268, issue.5, pp.1439-1447, 2001. ,
The coagulation system and its function in early immune defense, Thromb Haemost, vol.112, issue.4, pp.640-648, 2014. ,
Thrombin signalling and proteaseactivated receptors, Nature, vol.407, issue.6801, pp.258-264, 2000. ,
Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa, Proc Natl Acad Sci USA, vol.97, issue.10, pp.5255-5260, 2000. ,
Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene, J Biol Chem, vol.274, issue.45, pp.32225-32233, 1999. ,
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor, Proc Natl Acad Sci USA, vol.98, issue.14, pp.7742-7747, 2001. ,
Protease-activated receptors: contribution to physiology and disease, Physiol Rev, vol.84, issue.2, pp.579-621, 2004. ,
Proteinase-activated receptors, targets for kallikrein signaling, J Biol Chem, vol.281, issue.43, pp.32095-32112, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00320918
Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway, J Immunol, vol.179, issue.5, pp.2910-2917, 2007. ,
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates, J Biol Chem, vol.275, issue.34, pp.26333-26342, 2000. ,
Local protease signaling contributes to neural tube closure in the mouse embryo, Dev Cell, vol.18, issue.1, pp.25-38, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02441502
Proteinaseactivated receptor-2 mediates itch: a novel pathway for pruritus in human skin, J Neurosci, vol.23, issue.15, pp.6176-6180, 2003. ,
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism, Nat Med, vol.6, issue.2, pp.151-158, 2000. ,
The enteric nervous system in inflammation and pain: the role of proteinaseactivated receptors, Can J Gastroenterol, vol.17, issue.10, pp.589-592, 2003. ,
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway, Nat Med, vol.7, issue.7, pp.821-826, 2001. ,
Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response, Endocr Rev, vol.26, issue.1, pp.1-43, 2005. ,
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling, Nat Med, vol.10, issue.5, pp.502-509, 2004. ,
Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation, Nat Med, vol.17, issue.11, pp.1490-1497, 2011. ,
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice, Cancer Res, vol.68, issue.17, pp.7219-7227, 2008. ,
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease, Blood, vol.123, issue.11, pp.1747-1756, 2014. ,
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis, Oncogene, vol.21, issue.23, pp.3765-3779, 2002. ,
The epidermal barrier function is dependent on the serine protease CAP1/Prss8, J Cell Biol, vol.170, issue.3, pp.487-496, 2005. ,
TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition, Biochem J, vol.461, issue.3, pp.487-495, 2014. ,
Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine, Proc Natl Acad Sci, vol.107, issue.9, pp.4200-4205, 2010. ,
ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1, EMBO Mol Med, vol.2, issue.1, pp.26-37, 2010. ,
A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a nonenzymatic co-factor for matriptase activation, J Biol Chem, vol.288, issue.26, pp.19028-19039, 2013. ,
Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice, Development, vol.136, issue.15, pp.2653-2663, 2009. ,
Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta, Mol Cell Biol, vol.25, issue.13, pp.5687-5698, 2005. ,
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development, Oncogene, vol.26, issue.11, pp.1546-1556, 2007. ,
Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation, PLoS Genet, vol.8, issue.8, p.1002937, 2012. ,
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors, Nucleic Acids Res, vol.42, pp.503-509, 2014. ,
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease, Am J Physiol Cell Physiol, vol.289, issue.2, pp.462-470, 2005. ,
Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor, Mol Cell Biochem, vol.337, issue.1-2, pp.259-266, 2010. ,
Nonhematopoietic PAR-2 is essential for matriptasedriven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis, Oncogene, vol.34, issue.3, pp.346-356, 2015. ,
PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin, Nat Commun, vol.2, p.161, 2011. ,
Regulated shedding of PAR1 N-terminal exodomain from endothelial cells, J Biol Chem, vol.279, issue.18, pp.18592-18599, 2004. ,
Opposite sorting of tissue factor in human umbilical vein endothelial cells and Madin-Darby canine kidney epithelial cells, Blood, vol.88, issue.4, pp.1339-1349, 1996. ,
The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice, J Biol Chem, vol.271, issue.35, pp.21536-21541, 1996. ,
Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2, J Biol Chem, vol.285, issue.26, pp.19959-19966, 2010. ,
Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells, Am J Physiol Cell Physiol, vol.301, issue.5, pp.1093-1103, 2011. ,
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium, J Biol Chem, vol.282, issue.16, pp.11849-11857, 2007. ,
The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors, J Biol Chem, vol.286, issue.7, pp.5756-5767, 2011. ,
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPStriggered interferon responses in mice, Blood, vol.125, issue.18, pp.2845-2854, 2015. ,
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition, J Mol Biol, vol.380, issue.2, pp.351-360, 2008. ,
Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin, J Biol Chem, vol.290, issue.6, pp.3529-3541, 2015. ,
Activation of hepatocyte growth factor and urokinase/ plasminogen activator by matriptase, an epithelial membrane serine protease, J Biol Chem, vol.275, issue.47, pp.36720-36725, 2000. ,
Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase, Blood, vol.108, issue.8, pp.2616-2623, 2006. ,
Binding of human factor VIIa to tissue factor induces cytosolic Ca21 signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor, J Biol Chem, vol.270, issue.9, pp.4650-4660, 1995. ,
Coagulation factors VII and X induce Ca21 oscillations in Madin-Darby canine kidney cells only when proteolytically active, J Biol Chem, vol.271, issue.46, pp.29034-29042, 1996. ,
Genetic evidence that proteaseactivated receptors mediate factor Xa signaling in endothelial cells, J Biol Chem, vol.277, issue.18, pp.16081-16087, 2002. ,
Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase, J Cell Physiol, vol.213, issue.1, pp.237-245, 2007. ,
Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development, Am J Pathol, vol.144, issue.1, pp.60-69, 1994. ,
Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells, Blood, vol.102, issue.9, pp.3224-3231, 2003. ,
Activation of endothelial cell protease activated receptor 1 by the protein C pathway, Science, vol.296, issue.5574, pp.1880-1882, 2002. ,
Matriptase initiates activation of epidermal prokallikrein and disease onset in a mouse model of Netherton syndrome, Nat Genet, vol.42, issue.8, pp.676-683, 2010. ,
Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation, J Biol Chem, vol.281, issue.44, pp.32941-32945, 2006. ,
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue, Proc Natl Acad Sci, vol.96, issue.20, pp.11054-11061, 1999. ,
Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase, J Biol Chem, vol.277, issue.12, pp.10539-10546, 2002. ,
Binding of factor VIIa to tissue factor on keratinocytes induces gene expression, J Biol Chem, vol.275, issue.9, pp.6580-6585, 2000. ,
Impaired wound healing in mice with a disrupted plasminogen gene, Nat Med, vol.2, issue.3, pp.287-292, 1996. ,
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1, J Cell Biol, vol.163, issue.4, pp.901-910, 2003. ,
c-Metinduced epithelial carcinogenesis is initiated by the serine protease matriptase, Oncogene, vol.30, issue.17, pp.2003-2016, 2011. ,
Wound repair and regeneration, Nature, vol.453, issue.7193, pp.314-321, 2008. ,
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome, J Clin Invest, vol.118, issue.10, pp.3453-3461, 2008. ,
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII, Cancer Res, vol.66, pp.9453-9460, 2006. ,
Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development, Blood, vol.116, issue.26, pp.6106-6113, 2010. ,
Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling, Nat Commun, vol.6, p.6776, 2015. ,
Tissue factoractivated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy, Cancer Res, vol.71, issue.20, pp.6492-6502, 2011. ,
Hemostatic factors, innate immunity and malignancy, Thromb Res, vol.129, issue.1, pp.1-5, 2012. ,
Inhibition of tissue factor signaling suppresses tumor growth, Blood, vol.111, issue.1, pp.190-199, 2008. ,
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation, Genes Dev, vol.19, issue.16, pp.1934-1950, 2005. ,